The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...

Committee for Medicinal Products for Human Use (CHMP) has recommended an update to Novo Nordisk’s Wegovy (semaglutide 2.4 mg) ...

The company noted that Wegovy is the first obesity medication to receive a positive opinion recommending a label update that reflects reduced symptoms and improved physical limitations and exercise ...

BAGSVAERD, Denmark I 19, 2024 I Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human ...

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

Fake Ozempic adds to a glut of counterfeit pharmaceuticals that kill around a million people each year, according to the WHO.

Fake Ozempic adds to a glut of counterfeit pharmaceuticals that kill around a million people each year, according to the WHO.

STORY: The European Union faces intermittent shortages of Ozempic ... meet runaway demand for Ozempic and its related obesity drug Wegovy. Some analysts forecast the obesity drug market could ...

The Northeast Microelectronics Coalition Hub announced on Wednesday that it had been awarded $37.8 million in federal ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any breaking news developments ...

The European Union is aiming to hold a vote to introduce definitive tariffs on electric vehicles imported from China on Sept.

For the second trading session in less than a week, Roche Holding ( RHHBY 3.83%) stock really took it on the chin Wednesday.